Cardiovascular risk assessment in the treatment of nonalcoholic steatohepatitis: a secondary analysis of the MOZART trial

Background: Nonalcoholic steatohepatitis (NASH) is associated with increased cardiovascular risk and mortality. No US Food and Drug Administration (FDA) approved therapies for NASH are available; clinical trials to date have not yet systematically assessed for changes in cardiovascular risk. This st...

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Steven C. Lin, Brandon Ang, Carolyn Hernandez, Ricki Bettencourt, Rashmi Jain, Joanie Salotti, Lisa Richards, Yuko Kono, Archana Bhatt, Hamed Aryafar, Grace Y. Lin, Mark A. Valasek, Claude B. Sirlin, Sharon Brouha, Rohit Loomba
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: SAGE Publishing 2016-03-01
Loạt:Therapeutic Advances in Gastroenterology
Truy cập trực tuyến:https://doi.org/10.1177/1756283X15621232

Những quyển sách tương tự